-
Longitudinal Study of Donor Specific Antibodies in a Pediatric Kidney Transplant Population; Response to Optimization of Anti-Proliferative Therapy.
-
Loss of Bat3 Could Promote Transplant Tolerance by Regulating CD4 + T Cells Function.
-
Low Dose Valganciclovir for CMV Prophylaxis in the First Year of Kidney Transplantation.
-
Low Incidence of Acute Rejection within the Six Months After Transplantation in HIV Recipients Treated with Raltegravir, the ANRS 153 Treve Trial.
-
Low Level Early Onset De Novo DSA's May Not Portend Early Graft Dysfunction in Kidney Transplant Recipients.
-
Low Level Light Laser Treatment Reduces Macrophage Retention and ROS Levels Following Tissue Injury.
-
Low-Dose Valganciclovir for Cytomegalovirus Prophylaxis in Intermediate Risk Renal Transplants: A Single Center Experience.
-
Lower Incidence of DSA-Induced Chronic Antibody-Mediated Rejection in Abo-Incompatible Renal Transplantation.
-
Lower Mean Tacrolimus Troughs Increase Risk of De Novo Donor-Specific Antibodies in the First Year of Kidney Transplant.
-
Lower Rates of Living Donation Among Transplant Centers Located in the Stroke Belt.
- « Previous Page
- 1
- …
- 102
- 103
- 104
- 105
- 106
- …
- 181
- Next Page »